📰 Eva Kalias News
Page 8 - Eva Kalias News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eva Kalias. Real-time updates on events, politics, business and more.
November 4, 2021
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, November 4, 2021 - Santhera Pharmaceuticals (SIX: SANN) announces the appointment of Stephanie Brown as President North America and
November 4, 2021
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, November 4, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces the appointment of...
November 4, 2021
Santhera Appoints Stephanie Brown as President North America and Member of the Executive Management Team - read this article along with other careers information, tips and advice on BioSpace
October 15, 2021
Ad hoc announcement pursuant to Art. 53 LR Cash and cash equivalents of CHF 8.0 million (as of June 30, 2021)Net revenue CHF 4.5 million (H1-2020: CHF 7.8 million)Net result for period of CHF -20.5
October 15, 2021
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Announces First Half-Year 2021 Financial Results and Updates on Corporate Progress
October 15, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
October 1, 2021
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, October 1, 2021: SIX Exchange Regulation has permitted Santhera to publish its interim report for the six-month period ended June 30
May 27, 2021
Santhera Pharmaceuticals Holding AG: Santhera Publishes Agenda for its Annual General Meeting the invitation to its Annual General Meeting (AGM) , at 10:30 . Invitation and agenda items for the AGM The invitation and agenda items for the Annual General Meeting can be viewed on Santheras website at https://www.santhera.com/investors-and-media/investor-toolbox/share-bondholder-meetings. Selected agenda items: increases As previously announced, the Board of Directors (BoD) proposes various ca...
May 7, 2021
is starting today on the SIX Swiss Exchange. On May 4, 2021, Santhera Pharmaceuticals Holding AG issued Senior Unsecured Convertible Bonds due 2024 (the 2021/24 Bonds) in the aggregate principal amount of CHF 30,270,375. The 2021/24 Bonds have been admitted to trading on the SIX Swiss Exchange. The first trading day is today, May 7, 2021. The ticker symbol of the 2021/24 Bonds is SAN21 and ISIN CH0563348744. As set out in the terms and conditions [1], the conversion period during which a ...
May 7, 2021
Santhera Pharmaceuticals Holding AG: Santhera gibt den ersten Handelstag der neuen Wandelanleihe an der SIX Swiss Exchange bekannt Pratteln, Schweiz, vorrangigen 375 mit Fälligkeit 2024 heute an der SIX Swiss Exchange beginnt. Am 4. Mai 2021 hat die Santhera Pharmaceuticals Holding AG eine vorrangige ungesicherte Wandelanleihe mit Fälligkeit 2024 (die Anleihe 2021/24) im Gesamtnennbetrag von CHF 30270 375 ausgegeben. Die Anleihe 2021/24 wurde zum Handel an der SIX Swiss Exchange zugelassen...